NCT02424539
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +9 more
- Locations
-
- GSK Investigational Site Xiamen, Fujian, China
- GSK Investigational Site Shenzhen, Guangdong, China
- GSK Investigational Site Changsha, Hunan, China
- GSK Investigational Site Changsha, Hunan, China